MYLAN N.V.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 693B | ||||||
| 584B | ||||||
| 372B | ||||||
| 332B | ||||||
| 294B |
